title: Hemodynamic and nonhemodynamic mechanism of experimental pulmonary edema in rats and the effect of anisodamine and tetramethylpyrazine--electron microscopic observation and measurement of pulmonary arterial, pulmonary arterial wedge and systemic arterial pressure (Part 2).
abstract: The pulmonary edema (PE) induced by adrenaline (AD) administration is similar to neurogenic PE. Anisodamine (ADM, 654-2, 30 mg/kg) and tetramethylpyrazine (TMP, 120 mg/kg) have shown significant preventive effects. Electron microscopic observation was carried out to study the changes of microvascular permeability, and the dynamic change of mean pulmonary arterial pressure (PAP, 40 rats), mean pulmonary arterial wedge pressure (PAWP, 20 rats) and mean carotid arterial pressure (CAP) were also measured. The results suggested that both ADM and TMP have significant inhibitory effects on PAWP and CAP increase, as well as on the damage responsible for the increase of microvascular and alveolar permeability.
authors.affiliation: Institute of Basic Medical Sciences, CAMS, Beijing.
authors.forename: S
authors.initials: S
authors.lastname: Dai
authors.forename: S
authors.initials: S
authors.lastname: Su
authors.forename: Y
authors.initials: Y
authors.lastname: Cao
authors.forename: R
authors.initials: R
authors.lastname: Sun
authors.forename: Y
authors.initials: Y
authors.lastname: Fan
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: Q
authors.initials: Q
authors.lastname: Si
authors.forename: Q
authors.initials: Q
authors.lastname: Xue
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D008297:Male; D011651:Pulmonary Artery / Q000648:ultrastructure; D011654:Pulmonary Edema / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D011669:Pulmonary Wedge Pressure / Q000187:drug effects*; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D012991:Solanaceous Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D011719:Pyrazines; D012991:Solanaceous Alkaloids; D014665:Vasodilator Agents; C003922:anisodamine; C017953:tetramethylpyrazine